Procurement for the Supply of Active Pharmaceutical Ingredient - Physostigmine Free Base

The Chemical Biological Radiological and Nuclear Protection Delivery Team is inviting expressions of interest in respect of a proposed contract for the development, process validation, manufacture and supply of Physostigmine free base as an Active Pharmaceutical Ingredient (API) for use in a Ministry of Defence (MOD) final medicinal product currently under development. The Supplier will be required to develop, scale-up and validate the manufacturing method, define a detailed specification and full characterisation...